In Vivo Neuropharmacology Scientist

Bristol-Myers Squibb Company; Cambridge (MA); On-site; USD 130,000 - 157,000; Full time

Benefits offered by this job

Flexible Time Off (FTO)

11 paid holidays per year

Global Shutdown between Christmas and

Stock options potential

Comprehensive benefits

Job summary

Bristol Myers Squibb is seeking a Scientist in In Vivo Pharmacology in Cambridge, MA. The role focuses on directing in vivo pharmacology studies in mice, analyzing PD readouts, and coordinating with CRO partners to advance neuroscience programs.

The ideal candidate will have a PhD in Neuroscience or related field and extensive experience with rodent models and molecular assays, contributing to transformational therapeutics in neurodegenerative diseases.

Qualifications

• Bachelor's degree required; 5+ years of academic and/or industry experience.
• PhD in Neuroscience or related field preferred.
• Experience with rodent models and in vivo pharmacology techniques.

Responsibilities

• Performs and directs in vivo pharmacology studies in mice including dosing and tissue collection.
• Analyzes pharmacodynamic and efficacy readouts such as mRNA/protein expression, neuropathology, and physiology.
• Manages in vivo studies at contract research organizations (CROs).
• Serves as in vivo pharmacology representative on program and platform teams.

Skills

In vivo pharmacology experience

Strong organizational and comunicação

Independent work

Detail-oriented

Adaptability

Education

Bachelor's Degree

PhD in Neuroscience or related field

Tools

Rodent stereotaxic surgery

In vivo bioluminescence imaging

Transcriptomics

Proteomics

Job description

Bristol Myers Squibb is seeking a Scientist in In Vivo Pharmacology in Cambridge, MA. The role focuses on directing in vivo pharmacology studies in mice, analyzing PD readouts, and coordinating with CRO partners to advance neuroscience programs.

The ideal candidate will have a PhD in Neuroscience or related field and extensive experience with rodent models and molecular assays, contributing to transformational therapeutics in neurodegenerative diseases.